ClinicalTrials.gg
Sign In

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Alnylam Pharmaceuticals clinical trials

The registry lists 84 studies whose lead sponsor is Alnylam Pharmaceuticals. 19 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.

Keep track of what changes. Save the Alnylam Pharmaceuticals studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
43
Recruiting
18
Terminated
10
Active, not recruiting
7
Approved for marketing
3
Withdrawn
1

Phase

Phase 1
34
Phase 2
30
Phase 3
15

Where

United Kingdom
53
United States
51
France
31
Spain
28
Germany
28
Canada
27

Registry sponsor names on this page

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Alnylam Pharmaceuticals.

  • Alnylam Pharmaceuticals
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    84 studies

Focus areas

Conditions Alnylam Pharmaceuticals leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Amyloidosis27

Studies

Recruiting first, then most recently updated. Showing 50 of 84. Browse all 84 →